Heads up: there was some very important patent news over the weekend. The European Patent Office has signalled that they are going to accept the claims in ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS. This is a key patent covering the composition of Veyonda and it's application to radio and chemo.
https://patentscope.wipo.int/search/en/detail.jsf?docId=EP237378018&tab=NATCOLLDOCUMENTS
You can see the latest office action at the bottom of the list; just a few formalities remain.
This is such a massive win for Noxopharm. Awesome, awesome news, IMHO and will be under the radar until Noxopharm can announce it is actually granted.
Patent news
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.5¢ | $2.964K | 26.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 53298 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 33616 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |